Adze Biotechnology
BiotechnologyCoral Gables, FL
Total funding$6.2M#18 of 32 in Biotechnology
Founded2019
SectorBiotechnology
HQCoral Gables
About
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers. It has exclusive licenses to oncolytic immunotherapies developed in the lab of Dr. Michael Barry of Mayo Clinic. The company was founded in 2019 and is based in Coral Gables, Florida.
Adze Biotechnology is one of 16 Biotechnology companies we track in South Florida — 2% of the region's 662 startups.
Similar companies
View allASP IsotopesBiotechnology | Est. 2021 | MIA | $372M |
SyncromuneBiotechnology | Est. 2020 | MIA | $155M |
Pasithea TherapeuticsBiotechnology | Est. 2020 | MIA | $104M |
Myosin TherapeuticsBiotechnology | Est. 2020 | MIA | $15M |
WeoBiotechnology | Est. 2017 | MIA | $10M |
Details
- Region
- South Florida / Miami
- City
- Coral Gables
- Founded
- 2019
- Sector
- Biotechnology
- Founders
- Michael Barry, Sidney Hopps
- Website
- adzebiotech.com
South Florida / Miami
South Florida anchors the state's fintech, crypto, and Latin America-facing economy, with a deep bilingual talent pool across Miami, Fort Lauderdale, and Palm Beach.
662companies
$21.0Braised